Jab1/Csn5: a new player driving the resistance to HER2-targeted therapies for breast cancer

被引：0
|
作者：
Claret, F. [1 ]
Vu, T. [1 ]
Shackleford, T. J. [1 ]
Allensworth, J. L. [1 ]
Zhang, Q. [1 ]
Esteva, F. J. [1 ]
Drakos, E. [1 ]
Zhang, R. [1 ]
Tian, L. [1 ]
Rassidakis, G. Z. [2 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Mol Therapeut Unit 950, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)70603-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
477
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [1] Jab1/Csn5 a new player driving the resistance to Her2-targeted therapies for breast cancer.
    Vu, Thuy T.
    Shackleford, Terry J.
    Zhang, Qingxiu
    Esteva, Francisco J.
    Drakos, Elias
    Tian, Ling
    Kute, Timothy
    Sahin, Aysegul A.
    Rassidakis, George Z.
    Claret, Francois X.
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [2] Jab1/Csn5 a new target in the resistant mechanism to HER2-targeted therapies for breast cancer
    Claret, Francois X.
    Thuy Vu
    Shackleford, Terry J.
    Allensworth, Jennifer
    Zhang, Qingxiu
    Tian, Ling
    Zhang, Ronghua
    CANCER RESEARCH, 2014, 74 (19)
  • [3] JAB1/CSN5: a new player in cell cycle control and cancer
    Terry J Shackleford
    Francois X Claret
    Cell Division, 5
  • [4] JAB1/CSN5: a new player in cell cycle control and cancer
    Shackleford, Terry J.
    Claret, Francois X.
    CELL DIVISION, 2010, 5
  • [5] Jab1/Csn5 as a novel driver for therapeutic resistance in HER2-positive breast cancer
    Vu, Thuy T.
    Shackleford, Terry
    Zhang, Qingxiu
    Oh, Do-Youn
    Zhou Fuling
    Pan, Yunbao
    Tian, Ling
    Drakos, Ilias
    Rassidakis, Georgios
    Le, Xiao-Feng
    Sahin, Aysegul
    Kute, Timothy
    Claret, Francois
    CANCER RESEARCH, 2012, 72
  • [6] Jab1/CSN5 as a Novel Target to Overcome the Resistance to Trastuzurnab in Her2-positive Breast Cancer
    Vu, T.
    Zhang, Q.
    Tian, L.
    Shackleford, T.
    Kute, T.
    Claret, F. X.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 155 - 155
  • [7] The emerging roles of Jab1/CSN5 in cancer
    Lin Wang
    Jun-Nian Zheng
    Dong-Sheng Pei
    Medical Oncology, 2016, 33
  • [8] The emerging roles of Jab1/CSN5 in cancer
    Wang, Lin
    Zheng, Jun-Nian
    Pei, Dong-Sheng
    MEDICAL ONCOLOGY, 2016, 33 (08)
  • [9] Targeting Jab1/CSN5 in nasopharyngeal carcinoma
    Pan, Yunbao
    Claret, Francois X.
    CANCER LETTERS, 2012, 326 (02) : 155 - 160
  • [10] MAbs against mammalian Jab1/CSN5 protein
    Kato, Jun-Ya
    HYBRIDOMA, 2006, 25 (06): : 387 - 387
12345